Prudential Financial’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79M | Buy |
151,586
+47,803
| +46% | +$1.51M | 0.01% | 925 |
|
|
2025
Q1 | $3.44M | Buy |
103,783
+43,872
| +73% | +$1.46M | ﹤0.01% | 1018 |
|
|
2024
Q4 | $2.06M | Buy |
59,911
+28,650
| +92% | +$986K | ﹤0.01% | 1289 |
|
|
2024
Q3 | $1.25M | Sell |
31,261
-2,810
| -8% | -$112K | ﹤0.01% | 1767 |
|
|
2024
Q2 | $1.03M | Sell |
34,071
-3,000
| -8% | -$90.5K | ﹤0.01% | 1823 |
|
|
2024
Q1 | $1.24M | Sell |
37,071
-440
| -1% | -$14.8K | ﹤0.01% | 1715 |
|
|
2023
Q4 | $1.21M | Sell |
37,511
-29,231
| -44% | -$944K | ﹤0.01% | 1722 |
|
|
2023
Q3 | $2.19M | Sell |
66,742
-2,948
| -4% | -$96.6K | ﹤0.01% | 1315 |
|
|
2023
Q2 | $2.45M | Buy |
69,690
+13,011
| +23% | +$458K | ﹤0.01% | 1282 |
|
|
2023
Q1 | $1.85M | Sell |
56,679
-11,745
| -17% | -$383K | ﹤0.01% | 1390 |
|
|
2022
Q4 | $3.77M | Buy |
68,424
+347
| +0.5% | +$19.1K | 0.01% | 994 |
|
|
2022
Q3 | $3.02M | Buy |
68,077
+5,490
| +9% | +$243K | 0.01% | 1090 |
|
|
2022
Q2 | $3.05M | Sell |
62,587
-27,680
| -31% | -$1.35M | ﹤0.01% | 1150 |
|
|
2022
Q1 | $4.39M | Buy |
90,267
+66,112
| +274% | +$3.22M | 0.01% | 1044 |
|
|
2021
Q4 | $1.03M | Buy |
+24,155
| New | +$1.03M | ﹤0.01% | 1866 |
|